相关实验视频
Updated: Jul 14, 2025

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.8K
在新诊断的2型糖尿病患者中,卡纳格利弗洛辛的缓解效果:多中心,并行组,随机,受控,开放标签试验的协议
Xue Yang1, Zhiwei He1, Li Yuan1
1Department of Endocrinology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
BMC endocrine disorders
|October 9, 2023
概括
这项研究比较了新诊断的患者2型糖尿病 (T2DM) 缓解的卡纳格利弗洛辛和甲胺. 它调查卡纳格利弗洛辛是否提供更高的缓解率,并探索T2DM缓解的潜在机制.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于治疗2型糖尿病 (T2DM) 缓解的口服低血糖剂的研究有限.
- 代谢手术,生活方式干预和密集胰岛素治疗对T2DM缓解有希望.
- 这项研究通过调查T2DM缓解的口服药物来弥补这一差距.
研究的目的:
- 在新诊断的T2DM患者中研究卡纳格利弗洛辛与甲福明的缓解效应.
- 探索这些药物诱导糖尿病缓解的潜在机制.
- 确定卡纳格利弗洛辛在实现T2DM缓解方面是否优于甲福明.
主要方法:
- 一个多中心,并行组,随机,受控,开放标签试验.
- 184名患有T2DM (持续时间≤3年) 的参与者被随机 (1:1) 分给卡纳格利弗洛辛或甲胺.
- 药物被用于3个月的目标葡萄糖后,随后对缓解率进行1年的随访.
主要成果:
- 这个部分是在研究完成后填写的.
- 该研究旨在提供关于缓解率的强有力的证据.
- 结果将阐明卡纳格利弗洛辛和甲胺的比较疗效.
结论:
- 该研究将确定卡纳格利弗洛辛在T2DM缓解率方面是否超过甲福尔明.
- 这些发现可能为-葡萄糖携带载体-2 抑制剂 (SGLT2is) 在T2DM缓解中的疗效提供了重要的证据.
- 该试验旨在提供对T2DM缓解作用机制的见解.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Dipeptidyl Peptidase 4 Inhibitors
192
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
192
Oral Hypoglycemic Agents: Biguanides and Glitazones
212
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
212
Glucagon-like Receptor Agonists
334
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
334
Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K

